Effect of depression on health care utilization in patients with end-stage renal disease treated with hemodialysis

2009 ◽  
Vol 20 (4) ◽  
pp. 411-414 ◽  
Author(s):  
Seyed Abbas Tavallaii ◽  
Mehdi Ebrahimnia ◽  
Navvab Shamspour ◽  
Shervin Assari
Keyword(s):  
Health Care ◽  
Renal Disease ◽  
Health Care Utilization ◽  
End Stage Renal Disease ◽  
Care Utilization ◽  
Stage Renal Disease ◽  
End Stage

Associations between health literacy and health care utilization and mortality in patients with coexisting diabetes and end‐stage renal disease: A prospective cohort study

2020 ◽  
Vol 25 (3) ◽  
pp. 405-427
Author(s):  
Konstadina Griva ◽  
Russell K. L. Yoong ◽  
Mooppil Nandakumar ◽  
Moothathamby Rajeswari ◽  
Eric Y. H. Khoo ◽  
...  
Keyword(s):  
Health Care ◽  
Cohort Study ◽  
Health Literacy ◽  
Renal Disease ◽  
Health Care Utilization ◽  
End Stage Renal Disease ◽  
Prospective Cohort ◽  
Care Utilization ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Health care trajectories and barriers to treatment for patients with end-stage renal disease without health insurance in Mexico: a mixed methods approach

2020 ◽  
Vol 19 (1) ◽  
Author(s):  
Marcela Agudelo-Botero ◽  
María Cecilia González-Robledo ◽  
Hortensia Reyes-Morales ◽  
Liliana Giraldo-Rodríguez ◽  
Mario Rojas-Russell ◽  
...  
Keyword(s):  
Health Care ◽  
Health Insurance ◽  
Mixed Methods ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Barriers To Treatment ◽  
Mixed Methods Approach ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals The Impact of Warfarin on Patients with End Stage Renal Disease

2014 ◽  
Vol 2014 ◽  
pp. 1-4
Author(s):  
Anahita Dua ◽  
Sapan S. Desai ◽  
Harvey J. Woehlck ◽  
Cheong J. Lee
Keyword(s):  
Renal Disease ◽  
Hospital Mortality ◽  
End Stage Renal Disease ◽  
Hospital Charges ◽  
Care Utilization ◽  
Chronic Obstructive ◽  
Chronic Obstructive Pulmonary Disorder ◽  
Stage Renal Disease ◽  
End Stage ◽  
The Impact

Introduction. A deficiency in vitamin K through the utilization of warfarin may result in increased vascular calcification and complications. This study aimed to determine the impact of warfarin administration on patients with end stage renal disease (ESRD) in a large, national sample. Methods. A retrospective analysis using the 2005–2010 National Inpatient Sample (NIS), a part of the Health Care Utilization Project (HCUP), was completed using ICD-9 diagnosis codes to capture patients with ESRD prescribed and not prescribed warfarin. Statistical analysis was through ANOVA and chi-squared testing. Results. From 2005–2010, 927,814 patients with ESRD were identified nationally. 3.5% (32,737) were prescribed warfarin. Patients prescribed warfarin had an average age of 64 years and 51% were male. For every comorbid condition (amputation, congestive heart failure, chronic obstructive pulmonary disorder, cerebrovascular accident, diabetes, hypertension, myocardial infarction, peripheral vascular diasese, and valvular disease) patients prescribed Warfarin had significantly higher rates of disease as compared to their nonwarfarin ESRD counterparts. ESRD patients prescribed warfarin had significantly shorter length of stay but increased hospital charges. They were more likely to be discharged to home and had significantly decreased in-hospital mortality. Conclusion. Patients with ESRD taking warfarin are more likely to have comorbidities and/or complications but have a decreased LOS and in-hospital mortality compared to their ESRD counterparts not administered warfarin.

scholarly journals Health care providers’ support of patients’ autonomy, phosphate medication adherence, race and gender in end stage renal disease

2016 ◽  
Vol 39 (6) ◽  
pp. 1104-1114 ◽  
Author(s):  
Ebele M. Umeukeje ◽  
Joseph R. Merighi ◽  
Teri Browne ◽  
Marcus Wild ◽  
Hafez Alsmaan ◽  
...  
Keyword(s):  
Health Care ◽  
Medication Adherence ◽  
Renal Disease ◽  
Health Care Providers ◽  
End Stage Renal Disease ◽  
Care Providers ◽  
Race And Gender ◽  
And Gender ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Elucidating variations in outcomes among older end-stage renal disease patients on hemodialysis in Fukuoka Prefecture, Japan

PLoS ONE ◽  
2021 ◽  
Vol 16 (5) ◽  
pp. e0252196
Author(s):  
Aziz Jamal ◽  
Akira Babazono ◽  
Yunfei Li ◽  
Takako Fujita ◽  
Shinichiro Yoshida ◽  
...  
Keyword(s):  
Health Care ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Renal Disease ◽  
Medical Care ◽  
End Stage Renal Disease ◽  
Hospital Length Of Stay ◽  
Fukuoka Prefecture ◽  
Stage Renal Disease ◽  
End Stage

Variations in health care outcomes and services potentially indicate resource allocation inefficiency. Therefore, this study was conducted to examine variations in mortality and hospitalization cases among end-stage renal disease (ESRD) patients receiving hemodialysis (HD) care from medical facilities located in 13 secondary medical care areas (SMAs) of Fukuoka prefecture, Japan. The research was designed as a retrospective, cross-sectional study using insurance claims data. The subjects of the study were older patients (over 65 years old) insured by the Fukuoka prefecture’s Latter-Stage Elderly Healthcare Insurance. Using an electronic claims database, we identified patients with chronic kidney disease (CKD) who had received HD care from April 1, 2017 to March 31, 2018. The CKD status was identified using International Classification of Disease, 10th revision code, and HD maintenance status was ascertained using specific insurance procedure codes. A total of 5,243 patients met our inclusion criteria and their records were subsequently reviewed. About 73% (n = 3,809) of patients had admission records during the period studied. Thus, the data regarding hospital length of stay (LOS) and admission costs were analyzed separately. Significant differences in terms of increased risks in hospitalization were evident in a number of SMAs. An increase in mortality risk due to heart failure and malignancy was observed in two separate SMAs. Also, analyzed LOS, total hospitalization cost, and cost per day according to SMAs showed statistically significant variations. The findings highlight the magnitude of the burden of CKD and ESRD in the community. The high prevalence of ESRD, associated mortality, and hospitalized HD patients signal the need for clinicians to assume broader roles in measures against chronic kidney disease through involvement in community awareness programs. To improve patient outcomes, improvement of regional health care provision, the level of medical care, and the development of existing human resources are needed.

Sign in / Sign up

Export Citation Format

Share Document